This page lists all pharmaceutical reports related to the field of Metabolic & Hormonal Disorders. The reports include market research reports and pipeline analyses.
Displaying 151 - 169 of 169 results
- Innovations in Protein Kinase Therapies: Company pipelines, therapeutic applications and market forecasts
- Biosimilars Series: Forecast Analysis
- The Global OTC Pharmaceutical Market 2009-2024
- In Vitro Diagnostics Market Analysis 2009-2024
- The Diabetes Market Outlook To 2014: Market dynamics, competitive landscape, emerging therapies
- World Diabetes Market Analysis, 2009-2023
- Monoclonal Antibody Therapeutics 2009-2024
- World Generics Market 2009-2024
- The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets
- Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
- Rx to OTC Switches 2009
- Obesity, Weight Loss and Diet Management Markets (Pharmaceutical, Surgical and Dietary Approaches)
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- Global Pharmaceutical Biotech Market 2010-2025
- Pipeline Insight: Endometriosis - New therapies near market while more innovative targets still needed
- Forecast Insight: Dyslipidemia - While the market collapses, a well designed clinical trial program pays dividends for Crestor
- What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and Other Vaccine Targets in the 2010-2020 Pipeline
- Commercial Insight: Cardiovascular and metabolic market overview
- Pipeline and Commercial Insight: Obesity - the $11 billion market that never was